Thursday, March 29, 2007

High dose copaxone

Randomized, double blind dose comparison study of glatiramer acetate in relapsing-remitting MS . Cohen JA et al. Neurology 2007; 68:939-944. The study screened treatment naive patients EDSS 1-5, one relapse in prior year, about 45 patients in each group. Compared 20 v 40 mg. Trend towards less relapses in higher dose group. More injection reactions in higher dose group. MRI scores showed a trend favoring the higher dose group.

No comments: